Daniel Sturm, MMS, PA-C, Samuel L. Gurevitz, PharmD, CGP, Cassidy Davidson, PA-S, Abigail Fritchley, PA-S, Audrey Wagaman, PA-S
Although accreditation for this CE/CME activity has expired, and the posttest is no longer available, you can still read the full article.
Expires November 30, 2015
Several million Americans, primarily those in their fifties and sixties, contracted hepatitis C virus (HCV) many years ago and are unaware of their infection and their risk for HCV-related liver disease. Screening at-risk patients is important because newer treatment regimens are curative and can reduce associated morbidity and mortality.
PROGRAM OVERVIEW Earn credit by reading this article and successfully completing the posttest and evaluation. Successful completion is defined as a cumulative score of at least 70% correct.
EDUCATIONAL OBJECTIVES • List the risk factors for HCV infection. • Identify who should be screened for HCV infection. • Discuss the symptoms, clinical course, diagnosis, and complications of chronic HCV infection. • Differentiate between the treatment of acute and chronic HCV infection. • Describe the challenges of treating HCV infection in patients who are coinfected with HIV.
FACULTY Daniel Sturm and Samuel L. Gurevitz are Assistant Professors in the Physician Assistant Program, College of Pharmacy and Health Sciences, at Butler University in Indianapolis. Cassidy Davidson,Abigail Fritchley, and Audrey Wagaman are students in the PA Program at Butler University. The authors have no significant financial relationships to disclose.
ACCREDITATION STATEMENT
This program has been reviewed and is approved for a maximum of 1.0 hour of American Academy of Physician Assistants (AAPA) Category 1 CME credit by the Physician Assistant Review Panel. [NPs: Both ANCC and the AANP Certification Program recognize AAPA as an approved provider of Category 1 credit.] Approval is valid for one year from the issue date of November 2014.
